LAVA Therapeutics Ownership | Who Owns LAVA Therapeutics?


OverviewForecastRevenueFinancialsChart

LAVA Therapeutics Ownership Summary


LAVA Therapeutics is owned by 29.94% institutional investors, 32.69% insiders, and 37.37% retail investors. Redmile group is the largest institutional shareholder, holding 7.71% of LVTX shares. Bruce is the top mutual fund, with 1.98% of its assets in LAVA Therapeutics shares.

LVTX Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockLAVA Therapeutics29.94%32.69%37.37%
SectorHealthcare Stocks 486.50%11.08%-397.59%
IndustryBiotech Stocks 304.14%11.08%-215.23%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Redmile group2.07M7.71%$2.74M
Bml capital management1.97M7.33%$2.60M
Sanofi1.92M7.14%$2.53M
Merck1.15M4.27%$1.52M
Bruce521.87K1.94%$688.87K
Pathway financial advisors102.50K0.38%$97.48K
Pnc financial services group65.00K0.24%$61.81K
Two sigma investments, lp48.77K0.18%$46.38K
Bnp paribas arbitrage, snc41.80K0.16%$39.75K
Lepercq de neuflize asset management31.00K0.12%$40.92K

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Bml capital management1.97M1.97%$2.60M
Sanofi1.92M1.44%$2.53M
Merck1.15M0.70%$1.52M
Redmile group2.07M0.29%$2.74M
Bruce521.87K0.22%$688.87K
Lepercq de neuflize asset management31.00K0.03%$40.92K
Pathway financial advisors102.50K0.02%$97.48K
Two sigma securities14.24K0.00%$18.79K
Tsfg400.000.00%$1.00K
Two sigma investments, lp48.77K0.00%$46.38K

Top Buyers

HolderShares% AssetsChange
Bnp paribas arbitrage, snc41.80K-41.80K
Ubs group18.43K-17.36K
Two sigma securities14.24K0.00%14.24K
Bml capital management1.97M1.97%10.00K
Lepercq de neuflize asset management31.00K0.03%8.00K

Top Sellers

HolderShares% AssetsChange
Alpha wave global, lp---87.40K
Two sigma investments, lp48.77K0.00%-53.99K
Tang capital management---53.10K
Sphera funds management---48.42K
Susquehanna group, llp---48.20K

New Positions

HolderShares% AssetsChangeValue
Bnp paribas arbitrage, snc41.80K-41.80K$39.75K
Jones financial companies lllp400.00-400.00$528.00

Sold Out

HolderChange
Northwestern mutual wealth management-20.00
Advisor group-1.11K
Jpmorgan chase-1.30K
Simplex trading-2.59K
Cibc private wealth group-6.00K

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Jun 30, 202520-8,051,83116.77%294.55%8-20.00%433.33%
Mar 31, 202521-8,044,89024.29%295.15%10-23.08%3-
Dec 31, 202421-8.70%6,472,86779.38%2413.32%13116.67%3-57.14%
Sep 30, 2024239.52%3,608,399-3.99%136.84%6-33.33%7133.33%
Jun 30, 202421-8.70%3,758,209-0.08%147.11%9-30.77%3-

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Bruce521.87K1.98%-
Mutual Fund Evli Hannibal156.83K0.60%-
Evli Hannibal156.83K0.60%-
Mandarine Global Microcap G EUR27.50K0.10%-
Fidelity Nasdaq Composite Index14.17K0.05%-

Insider Transactions Trends


DateBuySell
2025 Q1--

LVTX Ownership FAQ


Who Owns LAVA Therapeutics?

LAVA Therapeutics shareholders are primarily institutional investors at 29.94%, followed by 32.69% insiders and 37.37% retail investors. The average institutional ownership in LAVA Therapeutics's industry, Biotech Stocks , is 304.14%, which LAVA Therapeutics falls below.

Who owns the most shares of LAVA Therapeutics?

LAVA Therapeutics’s largest shareholders are Redmile group (2.07M shares, 7.71%), Bml capital management (1.97M shares, 7.33%), and Sanofi (1.92M shares, 7.14%). Together, they hold 22.18% of LAVA Therapeutics’s total shares outstanding.

Does Blackrock own LAVA Therapeutics?

BlackRock is not among the top 10 institutional shareholders of LAVA Therapeutics.

Who is LAVA Therapeutics’s biggest shareholder by percentage of total assets invested?

Bml capital management is LAVA Therapeutics’s biggest shareholder by percentage of total assets invested, with 1.97% of its assets in 1.97M LAVA Therapeutics shares, valued at 2.6M$.

Who is the top mutual fund holder of LAVA Therapeutics shares?

Bruce is the top mutual fund holder of LAVA Therapeutics shares, with 1.98% of its total shares outstanding invested in 521.87K LAVA Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools